Article Information
History
- August 25, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Simona Piccirellaa,*,
- Leander Van Nesteb,
- Christopher Fowlerc,
- Colin L Mastersc,
- Jurgen Frippd,
- James D. Doecked,
- Chengjie Xionge,
- Daniela Ubertif,g and
- Paul Kinnona
- aDiadem srl, Brescia, Italy
- bHalixo BV, Hoegaarden, Belgium
- cThe Florey Institute of Neuroscience and Mental Health, Parkville, Australia
- dThe Australian e-Health Research Centre, CSIRO, Herston, Australia
- eWashington University School of Medicine, Division of Biostatistics, Saint Louis, MO, USA
- fDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
- gMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
- ↵*Correspondence:
Simona Piccirella, s.piccirella{at}diademdx.com
Posted August 25, 2021.
A conformational variant of p53 (U-p53AZ) as blood-based biomarker for the prediction of the onset of symptomatic Alzheimer’s disease
